Losartan Potassium 25 MG Oral Tablet
INDICATIONS AND USAGE Hypertension Losartan potassium tablets, USP are indicated for the treatment of hypertension. Losartan potassium may be used alone or in combination with other antihypertensive agents, including diuretics. Nephropathy in Type 2 Diabetic Patients Losartan potassium tablets, USP are indicated for the Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. In this population, losartan potassium reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for dialysis or renal transplantation) (see CLINICAL PHARMACOLOGY, Pharmacodynamics and Clinical Effects ).
Virtus Pharmaceuticals LLC
ROUND WHITE II
II ROUND WHITE
Related Pills
Losartan Potassium 50 MG Oral Tablet
Virtus Pharmaceuticals LLC
bisoprolol fumarate and hydrochlorothiazide tablet
unichem pharmaceuticals (usa), inc.
bisoprolol fumarate and hydrochlorothiazide tablet
unichem pharmaceuticals (usa), inc.
advil dual action with acetaminophen ibuprofen acetaminophen tablet film coated
wyeth consumer healthcare llc
advil dual action with acetaminophen ibuprofen acetaminophen tablet film coated
wyeth consumer healthcare llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Losartan Potassium Tablets, USP are available as follows: 25 mg – Each white, round, biconvex film coated tablets debossed with "II" on one side and plain on other side contains 25 mg of losartan potassium, USP. Tablets are supplied in bottles of 30 (NDC 76439-140-30), 90 (NDC 76439-140-90), 500 (NDC 76439-140-50), 1000 (NDC 76439-140-11), and 10 × 10 (unit-dose tablets) (NDC 76439-140-10). 50 mg – Each white, round, biconvex, film coated tablets debossed with "I2" on scoreline side and plain on other side contains 50 mg of losartan potassium, USP. Tablets are supplied in bottles of 30 (NDC 76439-141-30), 90 (NDC 76439-141-90), 1000 (NDC 76439-141-11), and 10 × 10 (unit-dose tablets) (NDC 76439-141-10). 100 mg – Each white, oval, biconvex film coated tablets debossed with "I3" on one side and plain on other side contains 100 mg of losartan potassium, USP. Tablets are supplied in bottles of 30 (NDC 76439-142-30), 90 (NDC 76439-142-90), 1000 (NDC 76439-142-11), and 10 × 10 (unit-dose tablets) (NDC 76439-142-10). Storage Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [see USP Controlled Room Temperature]. Keep container tightly closed. Protect from light. Dispense in a tight, light-resistant container as defined in USP.
More pills like ROUND II